Swiss startup Lunaphore secures €21M to develop automated cancer research tools
Lunaphore Technologies SA, a Swiss life-sciences company, developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23 million (approx €21 million).